Merck KGaA to acquire Silence Therapeutics for US$1.3bn
- Location
- 🇩🇪 Germany / United Kingdom
- Sector
- Pharma
- Organisations
- Merck KGaA ↔ Silence Therapeutics
- Transaction
- Acquisition (100%)
- Volume
- about US$1.3bn
- Status
- announced
Merck KGaA is buying UK RNA specialist Silence Therapeutics for US$20 per depositary share in cash, 130% above the closing price on 16 October 2026; the deal is worth about US$1.3bn. Closing is expected in Q1 2027 (KSL citing Reuters, 19 October 2026; second source: Pulse 2.0, 19 October 2026).
Source: ksl.com ↗ · Archived copy ↗
Further sources: pulse2.com ↗ (Archived copy ↗)
Evidence: 2 independent sources · archived copy saved · How well sourced is Eurotrack?
More from: 🇩🇪 Germany · 🇬🇧 United Kingdom